We determined whether the expression level of FTH1P3 was correlated with the clinicopathological features of LSCC patients, including gender, age, primary location, T classification, differentiation, lymph node metastasis, and clinical stage. The gene discussed is FTH1P3; the disease is metastatic malignant neoplasm in the lymph nodes.